Watch Ticker

Annovis Bio, Inc.

Go to Annovis Bio, Inc. Website

$8.36

(%)
Live
Previous Close

$8.36

Day Range

$ - $

Previous Day Range

$ - $

Market Cap

$93.4 million USD

Day Vol.

Previous Day Vol.

Currency

USD

Primary Exchange

New York Stock Exchange

Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists o...

Community
  • 0 posts discussing
0

Watchers

0

Visitors

Recent News

Novo Nordisk's (NVO) shares rise 3.1% as the company meets co-primary endpoints in a late-stage study evaluating its investigational candidate, Mim8, for the treatment of haemophilia A.

Related tickers: NVO, LGND, ANIP, ANVS.

Read Full Article

MALVERN, Pa., May 13, 2024 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a clinical-stage drug platform company developing novel therapies for neurodegenerative diseases, provided updates from across the organization and announced first quarter financial results.

Related tickers: ANVS.

Read Full Article
Trending Tickers
BTTX

XNAS

$0.01
(%)
OPRT

XNAS

$4.23
(%)
PALI

XNAS

$6.24
(%)
PRSO

XNAS

$1.42
(%)
ACRV

XNAS

$0.00
(%)